| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |